Metsera
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i;...
Metsera Logo
About Metsera
Metsera, Inc. operates as a clinical-stage biotechnology company. The Company specializes in developing next-generation injectable and oral nutrient stimulated hormone, analog peptides to treat obesity, overweight, and related conditions. Metsera serves customers worldwide.
Address
3 World Trade Center, 175 Greenwich Street
New York, 10007
United States
Year founded
2022
Report inaccurate data
Request an update to help us keep the brand up-to-date.
